Below is a list of useful international documents related to biosafety, along with a brief description of each document.
- Use the dropdown to filter the entries by country.
- Use the up and down arrows in the header row to sort the table in ascending or descending order, based on the entries in each column.
- Use the search feature to look for a specific document, word, or phrase.
- Clicking on “Reset” will return the table to its original state, displaying all entries.
|Appendix P: Physical and Biological Containment for Recombinant or Synthetic Nucleic Acid Molecule Research Involving Plants||Appendix P specifies physical and biological containment conditions and practices suitable to the greenhouse conduct of experiments involving recombinant or synthetic nucleic acid molecule-containing plants, plant-associated microorganisms, and small animals.||USA||US National Institutes of Health||View||usa|
|A Practical Guide to Containment: Plant Biosafety in Research Greenhouses||The reader will find new information on containment strategies for research with exotics (non-native invasive species), pathogens, insects, and genetically engineered (GE) plant-manufactured pharmaceuticals and industrial compounds, and on high containment for quarantined organisms, including those on the Select Agent list.||USA||Virginia Polytechnic Institute and State University||View||usa|
|Biosafety Resource Book||This Biosafety Resource Book aims at providing biosafety regulators, policy-makers and members of national biosafety committees with reference materials that can be readily consulted beyond the training events, when the need arises.||UN||Food and Agriculture Organization (FAO)||View||un|
|Integrated Confinement System for Genetically Engineered Plants: A Comprehensive Approach to Biosafety for Confined Field Trials||The Integrated Confinement System for Genetically Engineered Plants provides model procedures and documents for the regulation and conduct of Confined Field Trials (CFTs) with genetically engineered (GE) plants. These models may be used by regulators and scientists in their efforts to develop a comprehensive national system ensuring biosafety, accountability and transparency in field evaluations of GE plants.||USA||Program for Biosafety Systems (PBS)||View||usa|
|Guideline for the Conduct of Food Safety Assessment of Foods Derived from Recombinant-DNA Animals, 2008||This Guideline supports the Principles for the Risk Analysis of Foods Derived from Modern Biotechnology. It addresses safety and nutritional aspects of foods consisting of, or derived from, animals that have a history of safe use as sources of food, and that have been modified by modern biotechnology to exhibit new or altered expression of traits.||UN||Food and Agriculture Organization (FAO)||View||un|
|Guideline for the Conduct of Food Safety Assessment of Foods Produced Using Recombinant-DNA Micro-Organisms, 2003||This Guideline supports the Principles for the Risk Analysis of Foods Derived from Modern Biotechnology and addresses safety and nutritional aspects of foods produced through the actions of recombinant-DNA microorganisms.||UN||Food and Agriculture Organization (FAO)||View||un|
|Guideline for the Conduct of Food Safety Assessment of Foods Derived from Recombinant-DNA Plants, 2003||This Guideline supports the Principles for the Risk Analysis of Foods Derived from Modern Biotechnology. It addresses safety and nutritional aspects of foods consisting of, or derived from, plants that have a history of safe use as sources of food, and that have been modified by modern biotechnology to exhibit new or altered expression of traits.||UN||Food and Agriculture Organization (FAO)||View||un|
|Principles for the Risk Analysis of Foods Derived from Modern Biotechnology, 2003||The purpose of these Principles is to provide a framework for undertaking risk analysis on the safety and nutritional aspects of foods derived from modern biotechnology. This document does not address environmental, ethical, moral and socio-economic aspects of the research, development, production and marketing of these foods.||UN||Food and Agriculture Organization (FAO)||View||un|
|An Explanatory Guide to the Cartagena Protocol on Biosafety||The main goal of the guide is to facilitate the understanding of the legal obligations of the Parties under the Cartagena Protocol on Biosafety. It is an explanatory guide, which attempts to provide an information base on the content and origin of the provisions of the Protocol.||Switzerland, UK||International Union for Conservation of Nature and Natural Resources (IUCN) and FIELD||View||switzerland uk|
|Cartagena Protocol on Biosafety||The Parties to this Protocol, being Parties to the Convention on Biological Diversity, hereinafter referred to as “the Convention”, Recalling Article 19, paragraphs 3 and 4, and Articles 8 (g) and 17 of the Convention, recalling also decision II/5 of 17 November 1995 of the Conference of the Parties to the Convention to develop a Protocol on Biosafety, specifically focusing on transboundary movement of any living modified organism.||UN||Secretariat of the Convention on Biological Diversity||View||un|
|Consensus Document on Molecular Characterisation Of Plants Derived from Modern Biotechnology||Molecular characterisation is one component of the science-based multi-disciplinary approach used in food, feed and environmental risk/safety assessment of plants derived from modern biotechnology. The molecular characterisation of these plants is used to gain an understanding of the genetic material introduced and expressed in them. The purpose of this document is to explain the scientific basis underlying the application of molecular characterisation to the food, feed and environmental risk/safety assessment of these plants.||OECD||OECD Working Group on the Harmonisation of Regulatory Oversight in Biotechnology and the OECD Task Force for the Safety of Novel Foods and Feeds||View||oecd|
|World Health Organization (WHO) – Laboratory Biosafety Manual (Third Edition)||WHO published the first edition of the Laboratory biosafety manual in 1983. Since 1983, many countries have used the expert guidance provided in the manual to develop codes of practice. A second edition of the manual was published in 1993, and this third edition was published in 2004.||World Health Organization||View|